Stance Capital’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.35M Sell
4,555
-577
-11% -$171K 0.65% 63
2025
Q4
$1.4M Buy
5,132
+10
+0.2% +$2.72K 0.52% 73
2025
Q3
$1.38M Buy
5,122
+297
+6% +$80.8K 0.51% 71
2025
Q2
$1.33M Buy
+4,825
New +$1.31M 0.5% 101
2025
Q1
Sell
-797
Closed -$185K 97
2024
Q4
$185K Buy
+797
New +$183K 0.11% 71

Other funds holding CME

Stance Capital's CME Position: Q1 2026 in Review

Stance Capital reduced its CME Group (CME) stake by 11% in Q1 2026, selling an estimated $171K and leaving 4,555 shares worth $1.35M. The position accounts for 0.65% of the portfolio, ranked #63.

Stance Capital first reported a position in CME in Q4 2024 and has held it in 5 quarters since. The position peaked at $1.4M in Q4 2025. 1,791 funds tracked by Wall St. Rank hold CME as of Q1 2026.

  • Stance Capital held 4,555 shares of CME Group worth $1.35M as of Q1 2026.
  • Stance Capital sold 577 CME Group shares in Q1 2026, an estimated $171K.
  • CME Group made up 0.65% of Stance Capital's portfolio in Q1 2026, its #63 holding.
  • Stance Capital first reported a position in CME Group in Q4 2024 and has held it in 5 quarters since.
  • Stance Capital's CME Group position peaked at $1.4M in Q4 2025.
  • 1,791 funds tracked by Wall St. Rank held CME Group as of Q1 2026.

Based on Stance Capital's 13F filing for Q1 2026, filed 14 May 2026.